GALERA THERAPEUTICS INC (GRTX) Stock Analyst Earnings Estimates
NASDAQ:GRTX - Nasdaq - US36338D1081 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A 398.12% | ||||||||
| EBITDA YoY % growth | -24.01M | -24.13M -0.50% | -50.42M -108.95% | -70.18M -39.19% | -72.59M -3.43% | -51.12M 29.58% | -46.692M 8.66% | N/A 112.83% | N/A -845.51% | |
| EBIT YoY % growth | -24.09M | -24.26M -0.71% | -50.69M -108.94% | -70.55M -39.18% | -73.37M -4.00% | -51.23M 30.18% | -46.951M 8.35% | N/A 66.13% | N/A -181.43% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -2.98 -29.98% | -3.13 -5.03% | -2.30 26.52% | N/A 19.46% | N/A 31.72% | N/A 37.02% |
All data in USD
| Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|
| EPS Q2Q % growth | 0.26 154.93% | -0.30 -5.64% | -0.31 5.51% |
| Revenue Q2Q % growth | |||
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | -9.69M 42.36% | -8.67M 21.82% | -9.18M -77.36% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2023 Q2Q % growth | -0.28 53.33% | -0.41 | 0.13 | 30.91% |
| Q2 2023 Q2Q % growth | -0.48 11.11% | -0.39 | -0.09 | -24.39% |
| Q1 2023 Q2Q % growth | -0.50 13.79% | -0.39 | -0.11 | -28.24% |
| Q4 2022 Q2Q % growth | -0.58 9.38% | -0.55 | -0.03 | -5.85% |
| Q3 2022 Q2Q % growth | -0.60 30.23% | -0.54 | -0.06 | -12.10% |
| Q2 2022 Q2Q % growth | -0.54 38.64% | -0.54 | 0.00 | -0.41% |
| Q1 2022 Q2Q % growth | -0.58 22.67% | -0.58 | 0.00 | 0.47% |
| Q4 2021 Q2Q % growth | -0.64 20.00% | -0.77 | 0.13 | 16.34% |
| Q3 2021 Q2Q % growth | -0.86 -24.64% | -0.78 | -0.08 | -10.18% |
| Q2 2021 Q2Q % growth | -0.88 -17.33% | -0.85 | -0.03 | -4.10% |
| Q1 2021 Q2Q % growth | -0.75 -1.35% | -0.85 | 0.10 | 11.49% |
| Q4 2020 Q2Q % growth | -0.80 38.93% | -0.72 | -0.08 | -10.82% |
| Q3 2020 Q2Q % growth | -0.69 | -0.79 | 0.10 | 12.22% |
| Q2 2020 Q2Q % growth | -0.75 | -0.77 | 0.02 | 3.04% |
| Q1 2020 Q2Q % growth | -0.74 | -0.71 | -0.03 | -4.24% |
| Q4 2019 Q2Q % growth | -1.31 | -0.56 | -0.75 | -133.09% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | N/A | N/A | 0% | 0% |